NDC product
Trumenba
NDC 0005-0100 · Wyeth Pharmaceutical Division of Wyeth Holdings LLC
Key facts
| Product NDC | 0005-0100 |
|---|---|
| Proprietary name | Trumenba |
| Nonproprietary name | meningococcal group B vaccine |
| Substances | NEISSERIA MENINGITIDIS GROUP B RECOMBINANT LP2086 A05 PROTEIN VARIANT ANTIGEN, NEISSERIA MENINGITIDIS GROUP B RECOMBINANT LP2086 B01 PROTEIN VARIANT ANTIGEN |
| Dosage form | INJECTION, SUSPENSION |
| Route | INTRAMUSCULAR |
| Labeler | Wyeth Pharmaceutical Division of Wyeth Holdings LLC |
| Product type | VACCINE |
| Marketing category | BLA |
| Application number | BLA125549 |
| Marketing start | Nov 5, 2014 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: